Form 8-K - Current report:
SEC Accession No. 0001193125-25-005010
Filing Date
2025-01-13
Accepted
2025-01-13 08:06:19
Documents
40
Period of Report
2025-01-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d921303d8k.htm   iXBRL 8-K 27003
2 EX-99.1 d921303dex991.htm EX-99.1 35611
6 GRAPHIC g921303ex99_1p10g1.jpg GRAPHIC 303517
7 GRAPHIC g921303ex99_1p11g1.jpg GRAPHIC 236560
8 GRAPHIC g921303ex99_1p12g1.jpg GRAPHIC 178737
9 GRAPHIC g921303ex99_1p13g1.jpg GRAPHIC 399275
10 GRAPHIC g921303ex99_1p14g1.jpg GRAPHIC 235683
11 GRAPHIC g921303ex99_1p15g1.jpg GRAPHIC 244997
12 GRAPHIC g921303ex99_1p16g1.jpg GRAPHIC 243249
13 GRAPHIC g921303ex99_1p17g1.jpg GRAPHIC 298416
14 GRAPHIC g921303ex99_1p18g1.jpg GRAPHIC 209023
15 GRAPHIC g921303ex99_1p19g1.jpg GRAPHIC 249731
16 GRAPHIC g921303ex99_1p1g1.jpg GRAPHIC 156745
17 GRAPHIC g921303ex99_1p20g1.jpg GRAPHIC 411451
18 GRAPHIC g921303ex99_1p21g1.jpg GRAPHIC 301590
19 GRAPHIC g921303ex99_1p22g1.jpg GRAPHIC 369120
20 GRAPHIC g921303ex99_1p23g1.jpg GRAPHIC 244015
21 GRAPHIC g921303ex99_1p24g1.jpg GRAPHIC 265323
22 GRAPHIC g921303ex99_1p25g1.jpg GRAPHIC 185765
23 GRAPHIC g921303ex99_1p26g1.jpg GRAPHIC 160231
24 GRAPHIC g921303ex99_1p2g1.jpg GRAPHIC 622457
25 GRAPHIC g921303ex99_1p3g1.jpg GRAPHIC 438200
26 GRAPHIC g921303ex99_1p4g1.jpg GRAPHIC 363563
27 GRAPHIC g921303ex99_1p5g1.jpg GRAPHIC 256231
28 GRAPHIC g921303ex99_1p6g1.jpg GRAPHIC 308355
29 GRAPHIC g921303ex99_1p7g1.jpg GRAPHIC 191447
30 GRAPHIC g921303ex99_1p8g1.jpg GRAPHIC 336250
31 GRAPHIC g921303ex99_1p9g1.jpg GRAPHIC 259018
  Complete submission text file 0001193125-25-005010.txt   10487959

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vera-20250113.xsd EX-101.SCH 2835
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vera-20250113_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vera-20250113_pre.xml EX-101.PRE 11251
42 EXTRACTED XBRL INSTANCE DOCUMENT d921303d8k_htm.xml XML 3658
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

EIN.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40407 | Film No.: 25524909
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)